OpenAI reverses course, retains nonprofit board control and converts to a Public Benefit Corporation to balance profit-making and its charitable mission.
Trump signs executive actions to boost domestic drug manufacturing and oversight of gain-of-function research, raising concerns over potential higher costs and shortages.
OpenAI reverses course, retains nonprofit board control and converts to a Public Benefit Corporation to balance profit-making and its charitable mission.
Trump signs executive actions to boost domestic drug manufacturing and oversight of gain-of-function research, raising concerns over potential higher costs and shortages.
